Event Type
Disclosure
Mandatory
Variant
8-K
. Entry into a Material Agreement. As previously disclosed, on August 22, 2024, BIOLASE, Inc., a Delaware corporation (the “Company”) received a written notice
. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, on June 17, 2024, the Nasdaq Sto
. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1* Forbearance Agreement dated as of August 31, 2024, by and between BIOLASE, Inc.